Group One Trading
LRMR icon

Group One Trading’s Larimar Therapeutics LRMR Stock Holding History

Group One Trading’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$557K Buy
123,700
+100,700
+438% +$402K ﹤0.01% 3243
2025
Q4 		$87.6K Sell
23,000
-570,400
-96% -$2.22M ﹤0.01% 5110
2025
Q3 		$1.92M Buy
593,400
+525,800
+778% +$1.97M ﹤0.01% 2357
2025
Q2 		$195K Buy
67,600
+67,100
+13,420% +$155K ﹤0.01% 4368
2025
Q1 		$1.07K Sell
500
-28,400
-98% -$89.8K ﹤0.01% 7158
2024
Q4 		$112K Buy
28,900
+20,000
+225% +$132K ﹤0.01% 4425
2024
Q3 		$58.3K Sell
8,900
-4,000
-31% -$32.1K ﹤0.01% 4553
2024
Q2 		$93.5K Buy
12,900
+8,600
+200% +$65.9K ﹤0.01% 4014
2024
Q1 		$32.6K Buy
+4,300
New +$33.5K ﹤0.01% 5053
2023
Q4 		– Sell
-2,000
Closed -$7.9K – 7836
2023
Q3 		$7.9K Buy
2,000
+1,600
+400% +$6.05K ﹤0.01% 6482
2023
Q2 		$1.25K Buy
+400
New +$1.63K ﹤0.01% 7216
2022
Q4 		– Sell
-500
Closed -$2K – 7725
2022
Q3 		$2K Sell
500
-500
-50% -$1.25K ﹤0.01% 7165
2022
Q2 		$2K Sell
1,000
-20,800
-95% -$61.4K ﹤0.01% 7417
2022
Q1 		$88K Buy
+21,800
New +$143K ﹤0.01% 5616
2021
Q4 		– Sell
-2,000
Closed -$23K – 8569
2021
Q3 		$23K Buy
2,000
+1,800
+900% +$21.6K ﹤0.01% 7089
2021
Q2 		$2K Buy
+200
New +$2.26K ﹤0.01% 7946
2020
Q2 		– Sell
-208
Closed -$2K – 6002
2020
Q1 		$2K Buy
+208
New +$2.73K ﹤0.01% 4983
2018
Q3 		– Sell
-258
Closed -$32K – 5417
2018
Q2 		$32K Buy
+258
New +$21.9K ﹤0.01% 4182
2018
Q1 		– Sell
-1,200
Closed -$67K – 5091
2017
Q4 		$67K Buy
1,200
+83
+7% +$3.74K ﹤0.01% 3574
2017
Q3 		$47K Buy
1,117
+84
+8% +$3.49K ﹤0.01% 3673
2017
Q2 		$44K Buy
+1,033
New +$52.8K ﹤0.01% 3569
2017
Q1 		– Sell
-1,308
Closed -$50K – 4833
2016
Q4 		$50K Sell
1,308
-275
-17% -$11.2K ﹤0.01% 3262
2016
Q3 		$63K Buy
1,583
+1,350
+579% +$61.3K ﹤0.01% 3209
2016
Q2 		$17K Sell
233
-6,209
-96% -$491K ﹤0.01% 3866
2016
Q1 		$516K Sell
6,442
-3,950
-38% -$312K 0.01% 1666
2015
Q4 		$784K Buy
10,392
+10,367
+41,468% +$1.67M 0.01% 1484
2015
Q3 		$10K Sell
25
-867
-97% -$391K ﹤0.01% 4295
2015
Q2 		$371K Buy
+892
New +$373K 0.01% 2036

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Group One Trading's LRMR Position: Q4 2025 in Review

Group One Trading sold out of Larimar Therapeutics (LRMR) in Q4 2025, closing a stake of 133,701 shares — an estimated $520K sold.

Group One Trading first reported a position in LRMR in Q3 2015 and held it in 27 quarters. The position peaked at $432K in Q3 2025. 136 funds tracked by Wall St. Rank hold LRMR as of Q4 2025.

  • Group One Trading reported no remaining Larimar Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 133,701 Larimar Therapeutics shares in Q4 2025, an estimated $520K.
  • Group One Trading first reported a position in Larimar Therapeutics in Q3 2015 and held it in 27 quarters.
  • Group One Trading's Larimar Therapeutics position peaked at $432K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.